FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ofer Eidelman

Research Profile

Chemicals & Drugs

Disorders

Devices

Anatomy

Cell Line

Occupations

Living Beings

Concepts & Ideas

Physiology

Procedures

Genetic Therapy

Co-author Network

Publications

TOP 3
Catherine E Jozwik; Harvey B Pollard; Meera Srivastava; Thomas Darling; Ofer Eidelman; QingYuan Fan; Pamela L Zeitlin
Antibody microarrays: analysis of cystic fibrosis.
Meera Srivastava; Ofer Eidelman; YELIZAVETA TOROSYAN; Catherine Jozwik; Roslyn B Mannon; Harvey B Pollard
Elevated expression levels of ANXA11, integrins β3 and α3, and TNF-α contribute to a candidate proteomic signature in urine for kidney allograft rejection.
Stephen W Rothwell; Merrily Poth; Chiedozie Ayika; Ofer Eidelman; Catherine Jozwik; Harkirtin McIver; Harvey B Pollard
Plasma Proteomic Signature in Overweight Girls Closely Correlates with Homeostasis Model Assessment (HOMA), an Objective Measure of Insulin Resistance.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ofer Eidelman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Catherine E Jozwik; Harvey B Pollard; Meera Srivastava; Thomas Darling; Ofer Eidelman; QingYuan Fan; Pamela L Zeitlin
Antibody microarrays: analysis of cystic fibrosis.
Methods in molecular biology (Clifton, N.J.) 2012;823():179-200.
2011: Meera Srivastava; Ofer Eidelman; YELIZAVETA TOROSYAN; Catherine Jozwik; Roslyn B Mannon; Harvey B Pollard
Elevated expression levels of ANXA11, integrins β3 and α3, and TNF-α contribute to a candidate proteomic signature in urine for kidney allograft rejection.
Proteomics. Clinical applications 2011;5(5-6):311-21.
2011: Stephen W Rothwell; Merrily Poth; Chiedozie Ayika; Ofer Eidelman; Catherine Jozwik; Harkirtin McIver; Harvey B Pollard
Plasma Proteomic Signature in Overweight Girls Closely Correlates with Homeostasis Model Assessment (HOMA), an Objective Measure of Insulin Resistance.
Human genomics and proteomics : HGP 2011;2011():323629.
2010: Andrea B Gyorgy; John Walker; Dan Wingo; Ofer Eidelman; Harvey B Pollard; Andras Molnar; Denes V Agoston
Reverse phase protein microarray technology in traumatic brain injury.
Journal of neuroscience methods 2010;192(1):96-101.
2010: Harvey B Pollard; Mark A Levine; Ofer Eidelman; Morris Pollard
Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer.
In vivo (Athens, Greece) 2010;24(3):249-55.
2010: Ofer Eidelman; Catherine Jozwik; Wei Huang; Meera Srivastava; Stephen W Rothwell; David M Jacobowitz; Xiaoduo Ji; Xiuying Zhang; William B Guggino; Jerry Wright; Jeff Kiefer; Cara Olsen; Nima Adimi; Gregory P Mueller; Harvey B Pollard
Gender dependence for a subset of the low-abundance signaling proteome in human platelets.
Human genomics and proteomics : HGP 2010;2010():164906.
2009: Denes V Agoston; Andrea Gyorgy; Ofer Eidelman; Harvey B Pollard
Proteomic biomarkers for blast neurotrauma: targeting cerebral edema, inflammation, and neuronal death cascades.
Journal of neurotrauma 2009;26(6):901-11.
2007: Meera Srivastava; YELIZAVETA TOROSYAN; Mark Raffeld; Ofer Eidelman; Harvey B Pollard; Lukas Bubendorf
ANXA7 expression represents hormone-relevant tumor suppression in different cancers.
International journal of cancer. Journal international du cancer 2007;121(12):2628-36.
2007: Harvey B Pollard; Meera Srivastava; Ofer Eidelman; Catherine Jozwik; Stephen W Rothwell; Gregory P Mueller; David M Jacobowitz; Thomas Darling; William B Guggino; Jerry Wright; Pamela L Zeitlin; Cloud P Paweletz
Protein microarray platforms for clinical proteomics.
Proteomics. Clinical applications 2007;1(9):934-52.
2006: Harvey B Pollard; Ofer Eidelman; Catherine Jozwik; Wei Huang; Meera Srivastava; Xiao-Duo Ji; Brighid McGowan; Christine Formas Norris; Tsuyoshi Todo; Thomas Darling; Peter J Mogayzel; Pamela L Zeitlin; Jerry Wright; William B Guggino; Eleanore Metcalf; William J Driscoll; Greg Mueller; Cloud Paweletz; David M Jacobowitz
De novo biosynthetic profiling of high abundance proteins in cystic fibrosis lung epithelial cells.
Molecular & cellular proteomics : MCP 2006;5(9):1628-37.
2006: Meera Srivastava; Ofer Eidelman; Catherine Jozwik; Cloud Paweletz; Wei Huang; Pamela L Zeitlin; Harvey B Pollard
Serum proteomic signature for cystic fibrosis using an antibody microarray platform.
Molecular genetics and metabolism 2006;87(4):303-10.
2005: Susanna Tchilibon; Jian Zhang; Qingfeng Yang; Ofer Eidelman; Haksung Kim; Hung Caohuy; Kenneth Alan Jacobson; Bette S Pollard; Harvey B Pollard
Amphiphilic pyridinium salts block TNF alpha/NF kappa B signaling and constitutive hypersecretion of interleukin-8 (IL-8) from cystic fibrosis lung epithelial cells.
Biochemical pharmacology 2005;70(3):381-93.
2004: Malka Nissim-Rafinia; Micha Aviram; Scott H Randell; Liat Shushi; Efrat Ozeri; Ornit Chiba-Falek; Ofer Eidelman; Harvey B Pollard; James R Yankaskas; Batsheva Kerem
Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation.
EMBO reports 2004;5(11):1071-7.
2004: Meera Srivastava; Ofer Eidelman; Jian Zhang; Cloud Paweletz; Hung Caohuy; QingFeng Yang; Kenneth Alan Jacobson; Eliahu Heldman; Wei Huang; Catherine Jozwik; Bette S Pollard; Harvey B Pollard
Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(20):7693-8.
2004: Meera Srivastava; Lukas Bubendorf; Mark Raffeld; christoph bucher; Joachim Torhorst; Guido Sauter; Cara Olsen; Olli Kallioniemi; Ofer Eidelman; Harvey B Pollard
Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2344-50.
2003: Meera Srivastava; Cristina Montagna; Ximena Leighton; Mirta Glasman; Shanmugam Naga; Ofer Eidelman; Thomas Ried; Harvey B Pollard
Haploinsufficiency of Anx7 tumor suppressor gene and consequent genomic instability promotes tumorigenesis in the Anx7(+/-) mouse.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(24):14287-92.
2002: Meera Srivastava; Ofer Eidelman; Ximena Leighton; Mirta Glasman; Gertrud Goping; Harvey B Pollard
Anx7 is required for nutritional control of gene expression in mouse pancreatic islets of Langerhans.
Molecular medicine (Cambridge, Mass.) 2002;8(12):781-97.
2002: Meera Srivastava; Preeti Kumar; Ximena Leighton; Mirta Glasman; Gertrud Goping; Ofer Eidelman; Harvey B Pollard
Influence of the Anx7 (+/-) knockout mutation and fasting stress on the genomics of the mouse adrenal gland.
Annals of the New York Academy of Sciences 2002;971():53-60.
2002: Ofer Eidelman; Shoshana BarNoy; Michal Razin; Jiang Zhang; Peter McPhie; George Lee; Zhen Huang; Eric J Sorscher; Harvey B Pollard
Role for phospholipid interactions in the trafficking defect of Delta F508-CFTR.
Biochemistry 2002;41(37):11161-70.
2002: Meera Srivastava; Ofer Eidelman; Harvey B Pollard
cDNA microarrays for pharmacogenomic analysis of cystic fibrosis.
Methods in molecular medicine 2002;70():21-9.
2001: Ofer Eidelman; Meera Srivastava; Jian Zhang; Ximena Leighton; Joshua C Murtie; Catherine Jozwik; Kenneth Alan Jacobson; DL Weinstein; E L Metcalf; Harvey B Pollard
Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
Molecular medicine (Cambridge, Mass.) 2001;7(8):523-34.
2001: Harvey B Pollard; Ofer Eidelman; Kenneth Alan Jacobson; Meera Srivastava
Pharmacogenomics of cystic fibrosis.
Molecular interventions 2001;1(1):54-63.
2001: Ofer Eidelman; J Zhang; Meera Srivastava; Harvey B Pollard
Cystic fibrosis and the use of pharmacogenomics to determine surrogate endpoints for drug discovery.
American journal of pharmacogenomics : genomics-related research in drug development and clinical practice 2001;1(3):223-38.
2001: Meera Srivastava; Lukas Bubendorf; L Nolan; Mirta Glasman; Ximena Leighton; G Miller; W Fehrle; Mark Raffeld; Ofer Eidelman; Olli Kallioniemi; sudhir srivastava; Harvey B Pollard
ANX7 as a bio-marker in prostate and breast cancer progression.
Disease markers 2001;17(2):115-20.
1999: Meera Srivastava; Ofer Eidelman; Harvey B Pollard
Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis.
Molecular medicine (Cambridge, Mass.) 1999;5(11):753-67.